Sinphar Pharmaceutical Co.,Ltd.

TWSE:1734.TW

30.7 (TWD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income 305.708245.046-184.525-117.773-86.706-87.681-52.811-34.924-58.659207.365409.989107.47863.925102.398112.339
Depreciation & Amortization 243.524266.714269.37250.423236.765238.802238.99259.338227.132193.006168.342162.97162.049145.268131.541
Deferred Income Tax 0000000000001.29300
Stock Based Compensation 000000000000800
Change In Working Capital -131.729-40.78691.07687.261-186.963-25.08745.647-15.551157.893-156.608-27.932-116.191-18.909-0.92275.141
Accounts Receivables 40.054-92.728-140.886167.644-64.452-47.81528.656-6.997-5.56310.819-44.408-48.702000
Inventory -102.181-39.62-15.945-114.447-78.94834.37289.13985.995164.313-127.318-222.872-76.573-29.65-20.021-19.615
Accounts Payables -31.974121.9217.045-15.78127.69827.022-29.86633.28453.378000000
Other Working Capital -37.628-30.359240.86249.845-71.261-59.459-43.492-101.546-6.42-29.29194.94-39.61810.74119.09994.756
Other Non Cash Items -121.133-45.676-40.377-73.519-42.582-46.532-11.955-121.679-45.833-95.183-253.30710.1929.22514.75-9.077
Operating Cash Flow 296.37425.298135.544146.392-79.48679.502219.87187.184280.533148.58297.092164.449225.583261.494309.944
Investing Activities:
Investments In Property Plant And Equipment -300.936-153.445-161.444-157.77-176.734-255.692-170.998-224.849-412.041-294.291-598.159-375.195-361.692-292.75-219.714
Acquisitions Net -7.925-8.552-14.729-13.267-5.1756.677-40.154-7.0740.3420134.0491.8-3.468-2.5980.004
Purchases Of Investments -2.45-9.676-43.44-212.69-122.362-153.357-49.096-2.791-46.221-55.565-149.575-88.673-60.221-1-24
Sales Maturities Of Investments 7.92543.4443.77207.66593.573231.0490228.531006.0875.54441.10624.03738.856
Other Investing Activites -31.1773.995-29.75410.382-0.145-8.089-6.605-7.016-22.027-19.626-10.09630.956-21.068-37.54617.405
Investing Cash Flow -334.563-124.238-205.597-165.68-210.843-179.412-226.699-13.199-480.289-369.482-617.701-355.568-405.343-309.857-187.449
Financing Activities:
Debt Repayment -31.503-399.065-103.915-145.732-28.301-62.811-141.255-134.921-237.035-285.972-146.279-388.263000
Common Stock Issued 30.043015.587.90418.1340.7280143.1270587.562360.0662.165441.17715.10616.915
Common Stock Repurchased 008500002800432207.7460000
Dividends Paid -167.722-33.544-33.544-33.545-16.772-33.544-16.772-32.254-129.017-119.46-89.595-52.264-83.042-66.544-37.422
Other Financing Activities -0.666169.284159.832206.54170.682-37.548144.419-125.265241.8354.244222.334-134.243365.35129.091-112.797
Financing Cash Flow -106.842-263.325122.953318.727182.211-8.281-13.608130.687-124.217618.374554.272-184.342723.48577.653-133.304
Other Information:
Effect Of Forex Changes On Cash -4.2035.036-1.8843.612-9.684-3.477-4.296-26.758-22.1212.975.695-1.8413.251-3.3029.947
Net Change In Cash -163.06742.77151.016303.051-117.802-111.668-24.732177.914-346.093410.442239.358-377.302546.97625.988-0.862
Cash At End Of Period 1,074.4891,237.5561,194.7851,143.769840.718958.521,070.1881,094.92917.0061,166.822756.38593.925971.227424.251398.263